Matching trials
1,724 results
- A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age: primary endpoint results, effect estimate with confidence interval,…
- A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment: primary endpoint results,…
- A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine: Complete Statistical AnalysisIndependent statistical analysis of A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs): Complete Statistical AnalysisIndependent statistical analysis of A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic…
- A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia: Complete Statistical AnalysisIndependent statistical analysis of A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC): primary endpoint…
- A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.: Complete Statistical AnalysisIndependent statistical analysis of A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.: primary endpoint results, effect estimate…
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus…
- A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Trial of Magnesium Dependent Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Magnesium Dependent Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01273883).
- A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic…
- A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects: primary endpoint results, effect estimate with confidence interval,…
- A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder: primary endpoint results, effect estimate with confidence…
- A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A-TREATIndependent statistical analysis of American Trial Using Tranexamic Acid in Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02578901).
- AASKA statistical analysis of the AASK phase 3 trial evaluating blood pressure targets and antihypertensive strategies in African American patients with hypertensive nephrosclerosis and chronic renal insufficiency.
- ABC-02Independent statistical analysis of ABC-02, a phase 3 randomized trial evaluating gemcitabine with or without cisplatin in patients with unresectable locally advanced or metastatic biliary tract tumors.
- AC-170Independent statistical analysis of Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ACCELERATEComplete statistical analysis of ACCELERATE (NCT01687998), a randomized phase 3 study of evacetrapib versus placebo in high-risk vascular disease, including trial design, composite cardiovascular endpoints, Cox modeling, ANOVA, confidence intervals, p-values, and…
- ACCESS IIndependent statistical analysis of Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ACCOASTIndependent statistical analysis of A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Acetaminophen Before Vaccines for Infants Study (AVIS): Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen Before Vaccines for Infants Study (AVIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00325819).
- Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00585559).
- Acetazolamide Efficacy in Ataxia in PMM2-CDG: Complete Statistical AnalysisIndependent statistical analysis of Acetazolamide Efficacy in Ataxia in PMM2-CDG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04679389).
- ACHIEVE IComplete statistical analysis of ACHIEVE I, a randomized, double-blind phase 3 trial of oral ubrogepant for the acute treatment of migraine with or without aura, including endpoint definitions, logistic regression, odds ratios,…
- ACIPAn independent statistical analysis of the randomized phase 3 ACIP study of treatment strategies for asymptomatic cardiac ischemia, based on the ClinicalTrials.gov record.
- ACOSOG Z0011An educational statistical analysis of ACOSOG Z0011, a randomized phase 3 trial of lymph node removal in women with stage I or stage IIA breast cancer, including its design, endpoints, planned statistical…
- AcTIndependent statistical analysis of the randomized phase 3 AcT trial comparing alteplase and tenecteplase in patients with acute ischemic stroke, including trial design, the modified Rankin Scale primary endpoint, planned analysis, statistical…
- ACT IIAn independent statistical analysis of ACT II, a randomized phase 3 trial of radiation therapy plus fluorouracil with or without additional chemotherapy in patients with primary anal cancer.
- ACTG 076Independent statistical analysis of ACTG 076, a phase 3 study of zidovudine in HIV-infected pregnant women and their infants, including trial design, statistical methodology, planned analysis, limitations, and interpretation.
- ACTIV-6: COVID-19 Study of Repurposed Medications: Complete Statistical AnalysisIndependent statistical analysis of ACTIV-6: COVID-19 Study of Repurposed Medications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04885530).
- ACTIVEIndependent statistical analysis of ACTIVE: Advanced Cognitive Training for Independent and Vital Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298558).
- Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval,…
- ACTIVE-WAn independent statistical analysis of ACTIVE-W (NCT00243178), a randomized phase 3 trial evaluating clopidogrel in atrial fibrillation and vascular risk, including its time-to-event endpoint, trial design, planned statistical analysis, and interpretation.
- ACTS-GCAn independent statistical analysis of ACTS-GC, a phase 3 randomized trial evaluating TS-1 (S-1) after surgery for gastric cancer, including design, endpoints, planned statistical methods, and interpretation.
- ACTT-3Independent statistical analysis of ACTT-3, the phase 3 randomized trial of remdesivir plus interferon beta-1a versus remdesivir plus placebo in COVID-19, including time-to-recovery, subgroup hazard ratios, safety, and statistical interpretation.
- Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates: Complete Statistical AnalysisIndependent statistical analysis of Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ad26.COV2.SIndependent statistical analysis of the phase 3 Ad26.COV2.S trial in healthy adults for COVID-19 prevention, including randomized design, influenza and SARS-CoV-2 immunogenicity endpoints, ANOVA, geometric mean ratios, non-inferiority, confidence intervals, and safety.
- Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage: Complete Statistical AnalysisIndependent statistical analysis of Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ADAPTSC+Independent statistical analysis of Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ADAURAIndependent statistical analysis of the ADAURA phase 3 trial of AZD9291 versus placebo after complete tumour resection in stage IB-IIIA non-small cell lung carcinoma, including disease-free survival, overall survival, trial design, methodology,…
- Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients: Complete Statistical AnalysisIndependent statistical analysis of Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00316719).
- ADHANDIndependent statistical analysis of A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy: primary endpoint results, effect…
- ADjoinIndependent statistical analysis of Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ADJUNCT ONE™Complete statistical analysis of the phase 3 ADJUNCT ONE™ trial of liraglutide as adjunct therapy to insulin in type 1 diabetes, including non-inferiority analysis of HbA1c, body-weight and insulin-dose results, hypoglycemia, methodology,…
- Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…